Literature DB >> 20702997

[Underlying examination in the imaging of 89Sr bremsstrahlung radiation].

Hitomi Oda1, Hideyuki Hara, Osamu Ueda, Hiroaki Kawamata, Hiroto Sakai, Yasuaki Katou, Tooru Kida, Masahiro Kubota.   

Abstract

The radiopharmaceutical strontium chloride ((89)Sr) has been released as a new means of pain relief for painful bone metastasis in cancer patients. Because (89)Sr is a pure beta-emitting nuclide, it was considered difficult to know its distribution in the body from outside. Imaging with a gamma camera using bremsstrahlung radiation has been reported as one method, but there has been little detailed basic examination. We examined the optimal energy window and collimator when imaging with a gamma camera using bremsstrahlung radiation produced from (89)Sr beta rays. The results showed that setting the energy window at 75 keV, which is the peak formed by the characteristic X-ray of lead that is produced by the interaction of bremsstrahlung radiation and lead, is optimal for imaging. Also important are the material of the collimator and the use of an MELP collimator.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702997     DOI: 10.6009/jjrt.66.764

Source DB:  PubMed          Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi        ISSN: 0369-4305


  2 in total

1.  Characteristic X-ray imaging for palliative therapy using strontium-89 chloride: understanding the mechanism of nuclear medicine imaging of strontium-89 chloride.

Authors:  Yoshiki Owaki; Kazumasa Inoue; Hiroto Narita; Keisuke Tsuda; Masahiro Fukushi
Journal:  Radiol Phys Technol       Date:  2017-01-04

2.  Subcutaneous Extravasation of Sr-89: Usefulness of Bremsstrahlung Imaging in Confirming Sr-89 Extravasation and in the Decision Making for the Choice of Treatment Strategies for Local Radiation Injuries Caused by Sr-89 Extravasation.

Authors:  Joji Kawabe; Shigeaki Higashiyama; Kohei Kotani; Atsushi Yoshida; Hiroyuki Tsushima; Takashi Yamanaga; Daisuke Tsuruta; Susumu Shiomi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2013
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.